v3.26.3
Unaudited Interim Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Issued capital
Share premium
Capital warrant and other reserves
Share compensation reserve
Retirement benefit reserve
Investment revaluation reserve
Exchange fluctuation reserve
Accumulated losses
Total
Balance at Dec. 31, 2022 $ 2,020 $ 148,113,631 $ 23,747 $ 30,967,747 $ 69,395   $ 2,465,576 $ (165,820,236) $ 15,821,880
Loss for the period   (172,600,513) (172,600,513)
Other comprehensive income/(loss) for the period:                  
Exchange differences on translation of foreign operations   (820,391) (820,391)
Fair value loss on non-current financial asset                
Remeasurement gains on defined benefit plan, net of tax (29,965)   (29,965)
Total comprehensive loss for the period (29,965)   (820,391) (172,600,513) (173,450,869)
Scrip dividend for Preference Shares 46 (46)  
Shares issued pursuant to share-based payment arrangement 3 2,358,717 (2,358,720)  
Shares issued upon exercise of Class C warrants 2,718 51,347,266   51,349,984
Capital Reorganization - Share Exchange (3,317) 3,317  
Repurchase and cancellation of Old Class A Ordinary Shares (14,170)   (14,170)
Capital Reorganization - Shares issued to acquire net assets of Bridgetown (as defined in Note 1) 2,497 153,544,381   153,546,878
Reclassification of warrant liabilities   12,049,646   12,049,646
Shares issued for the settlement of expenses 32 499,968   500,000
Shares issued upon the exercise of call option for loan notes 201 12,332,834   12,333,035
Reclassification of liabilities for long-term employee benefits 318,921   318,921
Equity-settled share-based payment arrangements 6,629,044   6,629,044
Balance at Dec. 31, 2023 4,200 368,185,898 12,392,314 35,238,071 39,430   1,645,185 (338,420,749) 79,084,349
Loss for the period   (37,787,339) (37,787,339)
Other comprehensive income/(loss) for the period:                  
Exchange differences on translation of foreign operations   3,738,760 3,738,760
Fair value loss on non-current financial asset                
Remeasurement gains on defined benefit plan, net of tax 11,731   11,731
Total comprehensive loss for the period 11,731   3,738,760 (37,787,339) (34,036,848)
Exercise of share options 159 787,437 (787,437)   159
Issuance of share for settlement of long-term employee benefit 4 301,765 (301,769)  
Equity-settled share-based payment arrangements 3,179,214   3,179,214
Balance at Dec. 31, 2024 4,363 369,275,100 12,090,545 37,629,848 51,161 5,383,945 (376,208,088) 48,226,874
Loss for the period   (2,233,386) (2,233,386)
Other comprehensive income/(loss) for the period:                  
Exchange differences on translation of foreign operations   (3,818,542) (3,818,542)
Fair value loss on non-current financial asset                
Remeasurement gains on defined benefit plan, net of tax 39,564   39,564
Total comprehensive loss for the period 39,564   (3,818,542) (2,233,386) (6,012,364)
Shares issued pursuant to share-based payment arrangement 155 3,457,209 (3,457,209)   155
Equity-settled share-based payment arrangements 745,096   (28,669) 716,427
Balance at Jun. 30, 2025 4,518 372,732,309 12,090,545 34,917,735 90,725   1,536,734 (378,441,474) 42,931,092
Balance at Dec. 31, 2024 4,363 369,275,100 12,090,545 37,629,848 51,161 5,383,945 (376,208,088) 48,226,874
Loss for the period (5,178,975) (5,178,975)
Other comprehensive income/(loss) for the period:                  
Exchange differences on translation of foreign operations (4,943,869) (4,943,869)
Fair value loss on non-current financial asset (56,000) (56,000)
Remeasurement gains on defined benefit plan, net of tax 73,931   73,931
Total comprehensive loss for the period 73,931 (56,000) (4,943,869) (5,178,975) (10,104,913)
Exercise of share options 34 867,780 (867,780)   34
Issuance of share for settlement upon vesting of restricted share units 191 1,885,376 (1,885,567)  
Equity-settled share-based payment arrangements 1,288,714   1,288,714
Balance at Dec. 31, 2025 4,588 372,028,256 12,090,545 36,165,215 125,092 (56,000) 440,076 (381,387,063) 39,410,709
Loss for the period (7,946,793) (7,946,793)
Other comprehensive income/(loss) for the period:                  
Exchange differences on translation of foreign operations 2,511,922 2,511,922
Fair value loss on non-current financial asset (71,000) (71,000)
Remeasurement gains on defined benefit plan, net of tax 11,040 11,040
Total comprehensive loss for the period 11,040 (71,000) 2,511,922 (7,946,793) (5,494,831)
Shares issued pursuant to share-based payment arrangement 68 819,175 (819,243)
Equity-settled share-based payment arrangements 556,518 556,518
Balance at Jun. 30, 2026 $ 4,656 $ 372,847,431 $ 12,090,545 $ 35,902,490 $ 136,132 $ (127,000) $ 2,951,998 $ (389,333,856) $ 34,472,396